Articles On Elixinol Global (ASX:EXL)

Cannabis and hemp are back in the US headlines. And one local pot stock — Elixinol — is feeling a high…share price. At time of writing Elixinol Global Ltd [ASX:EXL] is up 11%. Though it did peak even higher at a 12.28% gain prior in early t...

Cannabis is a dynamic and rapidly growing sector with strong growth prospects. Countries like Canada, Germany, Norway, Thailand, Chile, Argentina, and Greece have legalised the use of medicinal cannabis, after recognizing its possible benef...

One of the fastest-growing plants, hemp or industrial hemp, is a strain of plant species Cannabis sativa, cultivated specifically for the industrial uses of its derived products. Hemp contains a higher concentration of cannabidiol (CBD), di...

Marijuana stocks or pot stocks are catching investors’ eyes these days after the legalisation of cannabis for medicinal and recreational use in many countries.  According to the Australian health department, all the cannabis formulations su...

The Cann Group Ltd (ASX: CAN) share price is having a rare positive day of trade. In morning trade the cannabis company’s shares are up 4% to $1.05. This has reduced its one-month decline to approximately 30%. Why is the Cann Group share p...

Cannabis Shares Valuing a cannabis company is becoming an increasingly difficult task. Lately, the cannabis shares have been taking a beat in the domestic markets, falling from their respective all-time highs. The table below provides you w...

ASX cannabis shares have fallen out of favour recently, with the Althea Group (ASX: AGH), Cann Group Ltd (ASX: CAN) and Elixinol Global Ltd (ASX: EXL) share prices all tumbling to new lows. However, there is one cannabis share that has...

Each Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. The analysis is based on the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price actio...

Cannabis is a fast-growing industry with a dynamic and rapidly changing prospects, the medicinal cannabis stocks are progressing on the right track to capture investors’ attention and maximum addressable market. Players dealing in medicinal...

Given it’s chock full of omega acids and other goodies, hemp is acknowledged as one of nature’s finest super foods. But how much of a good thing is too much? The issue has been occupying the collective minds of the US Food and Drug Administ...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

In afternoon trade the S&P/ASX 200 index is on course to give back yesterday’s gains. At the time of writing the benchmark index is down 0.25% to 6,655.5 points. Four shares that have fallen more than most today are listed below. Here’...

Botanix Pharmaceuticals’ (ASX:BOT) shares have halved after its anti-acne drug failed its clinical trial. If you read most of the company’s announcement and you’d would have thought the 368 patient trial was a success. Its drug, BTX 1303, w...

The Elixinol Global Ltd (ASX: EXL) share price has come under significant selling pressure today after returning from a trading halt. The diversified cannabis company’s shares crashed 10% lower to $1.92 this morning. Why did the Elixinol G...

Cannabis is a high-growth industry with a rapidly changing environment. The companies discussed in this article are ASX-listed medicinal cannabis players. Medicinal cannabis companies are increasingly catching attraction from investors. As...

Government bodies across the globe are legalising the manufacturing and consumption of medical cannabis products, resulting in vast opportunities for investors. In 2018, Canada became the second largest country in the world to legalise cann...

Cannabis industry in Australia is growing at a fast pace, and government authorities across the country are creating a lot of prospects for investors by legalising medicinal cannabis. Moreover, it is being assumed that the Australia cannabi...

2018 witnessed several catalysts for the legal cannabis industry, with countries legalising medicinal cannabis, public and private sector getting into constructive discussions about the calibre and cons of the pot industry from a business p...

ASX cannabis shares are struggling to gain momentum in FY19. Interest in the sector has dwindled and sentiment is waning. This could be explained by the short-sighted nature of the market. When there isn’t any groundbreaking news released...

Usually, when lawmakers take a step further on the road to legalisation, there’s a flurry of speculation around cannabis stocks. However, despite positive news for marijuana enthusiasts from the Australian Capital Territory Legislative Ass...

Elixinol Global (ASX:EXL): It's Not Easy Being Green It’s high time we checked in on Elixinol Global (ASX:EXL) post the release of the company’s 1H19 results late last month and following a very busy last several months which we’ll summaris...

Do you know that on this day in 1970 the great American rock guitarist, singer, and songwriter Jimi Hendrix passed away. James Marshall 'Jimi' Hendrix’s mainstream career lasted only four years, but he is widely regarded as one of the most...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The Elixinol Global Ltd (ASX: EXL) share price has had a rough 2019, falling from highs of $5.69 on 9 April to as low as $2.12 on 12 September. However, EXL shares began to bounce last week. Today, the stock is up 2.71% at the time of writ...

With growth companies operating on high-flying price-to-earnings multiples, their stock prices are highly sensitive to any company-specific or market wide news. These three stocks have had a rather tough month, which could open up buying o...

The Althea Group Holdings Ltd (ASX: AGH) share price has been amongst the best performers on the Australian share market over the last 12 months. Since its 20 cents per share IPO in September of last year, the cannabis company’s shares hav...

Cannabis was once synonymous with drugs, marijuana, ill-health and the scourges of our society. Presently, cannabis is associated with medication, business and legalisation. This proves that we have come a long way in the cannabis space, an...

Cannabis: An Overview The cannabis industry is booming at a rapid pace with governments across the globe creating the opportunities for investors by legalising recreational and medicinal cannabis. Legalisation of cannabis by government auth...

The Cann Global Ltd (ASX: CGB) share price has been a big mover on the Australian share market on Thursday. The cannabis company’s shares are up 16% to 2.9 cents in afternoon trade following the release of a positive update. What did Cann...

After initially charging higher following the release of its half year results, the Elixinol Global Ltd (ASX: EXL) share price has tumbled lower in late morning trade. At the time of writing the cannabis company’s shares are down 4% to $2....

One of Australia's leading medicinal cannabis companies saw 19 per cent year-on-year revenue growth for the first half of 2019, but the outcome would have likely been better if it hadn't pulled out of a low-margin private label business ear...

August proved a busy month for ASX investors. Now that earnings season is coming to a close, it’s time to start gearing up for a strong September. Here are three ASX growth companies that I’ll be keeping close watch of next month.   Nanoso...

The increasing use of medical cannabis products has prompted many countries to soften the regulations regarding the manufacturing and consumption of cannabis products. Last year, Canada became the second and the largest country in the world...

‘Pot stocks’ were making headlines in 2018. California, one of the world’s biggest economies and the most populous state in the US, finally enacted legislation to legalise the recreational use of cannabis. It joined a growing list of US st...

Special Report: The rapidly growing cannabis and CBD sectors are turning to the marketing industry to help them realise their potential, says Domenic Carosa, CEO of global media and marketing company Crowd Media. Spurred by growing support...

If you weren’t aware already, earnings season is upon us. If there’s any company you think is on the rise, now is a great time to bet your dollars. Here’s how I’d invest $10,000 this August. Aristocrat Leisure Limited (ASX: ALL) – $4,000 A...

The legalisation of medical cannabis in southeast Asia is gathering steam with news that Thailand has officially started distributing cannabis oil to eligible patients over the past week. Advocates hope that the move is a sign of things to...

ASX marijuana shares have come under pressure following general market volatility and capital raisings. While I believe the shares are not in the ‘buy zone’ yet, they are certainly worth keeping an eye out for. Here are three ASX Marijuana...

Crowd Media Holdings Limited (ASX: CM8), based in Victoria, Australia, is a global media and marketing company operating through two primary business segments. The Mobile Division, which is dedicated to the creation of content such as appli...

The MGC Pharmaceuticals Ltd (ASX: MXC) share price could be on the move today after the cannabis company released a late announcement on Thursday. What did MGC Pharmaceuticals announce? On Thursday MGC Pharmaceuticals provided an update on...

Cannabis company Elixinol Global (ASX: EXL) has unveiled a new manufacturing and supply agreement with Altmed Pets, otherwise known as Pet Releaf, in a deal that has the potential to add significant value to its balance sheet in the near te...

The company is a global leader in the cannabis industry, selling hemp-derived CBD dietary supplements, hemp food and wellness products as well as holding a manufacturing licence for medicinal cannabis.

Shares in Immuron took a 17 per cent hit this morning after the company revealed its IMM-124E drug did not work in a trial with patients suffering from severe alcoholic hepatitis. Immuron (ASX:IMM), which is developing oral drugs for gut di...

The Elixinol Global Ltd (ASX: EXL) share price could push higher today following the release of an announcement out of the medicinal cannabis company this morning. What did Elixinol Global announce? This morning Elixinol Global announced t...

Australia has established its strong position in the contemporary world that is welcoming the good side of cannabis with open arms, amid the recreational legalising debates. The country joined the bandwagon of Alaska, Canada, North Korea an...

Generally speaking, I try to let my winners run, even if I do take some profits. Today, with momentum changing, escalating trade wars and Hong Kong in chaos, I'm going to ditch some of my lower conviction positions that I have been umm-ing...

Data analytics company Nielsen predicts that the American cannabis market will hit $US41 billion ($59.5 billion) by 2025 — a fivefold increase over 2018. While a good chunk of cannabis products are still illegal in the US, Nielsen reckons s...

The Elixinol Global Ltd (ASX: EXL) share price was a positive performer on Tuesday following the release of its second quarter update. The shares of the manufacturer and global distributor of industrial hemp based dietary supplement and sk...

The progress of the Australian medical cannabis industry since its legalisation indicates that the country is following the footsteps of Canada, attracting established international players. The market experts believe that the Australian ca...